In brief: Alzheimer’s drug fails late-stage test
TRENTON, N.J. – An experimental Alzheimer’s treatment has failed to slow the disease in one late-stage study.
Pfizer, which is testing bapineuzumab with partner Johnson & Johnson, said the injected drug didn’t slow mental or functional decline in patients with mild or moderate Alzheimer’s disease. The study included about 1,100 patients who carry a gene called ApoE4, which gives people a higher risk of developing the memory-robbing disorder.
About half the population does not carry that gene, however, and studies in patients without the gene continue.
Assault victim won’t be charged
LOUISVILLE, Ky. – A Kentucky teenager frustrated by light punishment for two boys who pleaded guilty to sexually assaulting her was spared Monday from having to face a contempt charge for naming them on Twitter in violation of a court order.
The case of Savannah Dietrich, 17, quickly gathered supporters nationwide who were upset that the victim of an assault could be punished for speaking out against her attackers.
On Monday, attorneys for the boys dropped their motion to charge her with contempt.